We are live on
!
Find out more
EMB
Elefante Mark B Portfolio holdings
AUM
$182M
1-Year Est. Return
17.71%
This Fund
S&P 500
This Quarter
Est. Return
+5.67%
1 Year Est. Return
+17.71%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$3.72M
AUM Growth
–
Cap. Flow
+$3.74M
Cap. Flow
% of AUM
100.6%
Top 10 Holdings %
Top 10 Hldgs %
76.38%
Holding
14
New
14
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$347K |
| 2 |
FISV
Fiserv Inc
FISV
|
+$336K |
| 3 |
Apple
AAPL
|
+$324K |
| 4 |
Mastercard
MA
|
+$315K |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$257K |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 34.05% |
| 2 | Technology | 23.33% |
| 3 | Industrials | 11.93% |
| 4 | Financials | 8.41% |
| 5 | Communication Services | 7.26% |
Similar funds
CIA
HWM
AFS
TFP
CFG
CFG
NED
RS
Elefante Mark B's Q4 2015 Portfolio in Review
Q4 2015 is the first quarter with a 13F filing on record for Elefante Mark B, which disclosed 14 positions worth $3.72M. Its ten largest holdings account for 76% of the portfolio.
Its largest position is CVS Health: 3,540 shares worth $346K.
By sector, the portfolio is most concentrated in Healthcare at 34% of assets, followed by Technology and Industrials.
- Elefante Mark B's largest Q4 2015 buy was CVS Health: 3,540 shares worth $346K.
- Elefante Mark B's ten largest holdings make up 76% of its $3.72M portfolio in Q4 2015.
- Elefante Mark B disclosed 14 positions in Q4 2015, its first 13F filing on record.
Based on Elefante Mark B's 13F filing for Q4 2015, filed 12 Feb 2016.